
Annual report 2023
added 12-27-2025
Profound Medical Corp. Market Cap 2011-2026 | PROF
As of April 09, 2026 Profound Medical Corp. has a market cap of $ 180 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 230 M | 228 M | 121 M | 88.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 230 M | 88.1 M | 167 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
13.9 B | $ 176.83 | 5.97 % | $ 13.2 B | ||
|
Alphatec Holdings
ATEC
|
2.07 B | $ 11.66 | 5.71 % | $ 1.75 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 34.0 | 9.71 % | $ 1.57 B | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.18 | 2.01 % | $ 1.65 B | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
7.81 B | $ 281.15 | 1.13 % | $ 7.93 B | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.62 | 1.67 % | $ 38.6 M | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 38.25 | 4.31 % | $ 5.7 K | ||
|
Boston Scientific Corporation
BSX
|
113 B | $ 62.56 | 1.15 % | $ 92.6 B | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
175 M | $ 24.4 | 2.61 % | $ 206 M | ||
|
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | ||
|
ClearPoint Neuro
CLPT
|
316 M | $ 9.17 | 1.1 % | $ 260 M | ||
|
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
12.5 B | $ 91.96 | 2.13 % | $ 12.4 B | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
Inogen
INGN
|
160 M | $ 6.67 | -1.91 % | $ 177 M | ||
|
Inspire Medical Systems
INSP
|
1.76 B | $ 53.38 | -1.89 % | $ 1.57 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.03 | - | $ 17.4 M | ||
|
Integer Holdings Corporation
ITGR
|
2.98 B | $ 87.48 | 2.78 % | $ 3.04 B | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
OrthoPediatrics Corp.
KIDS
|
437 M | $ 16.01 | 1.59 % | $ 376 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
3.81 B | $ 64.66 | 1.76 % | $ 3.53 B | ||
|
LENSAR
LNSR
|
71.3 M | $ 5.53 | -1.78 % | $ 66.1 M | ||
|
Butterfly Network
BFLY
|
766 M | $ 4.14 | 2.22 % | $ 876 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
EDAP TMS S.A.
EDAP
|
139 M | $ 3.37 | -0.88 % | $ 126 M | ||
|
Myomo
MYO
|
33.9 M | $ 0.68 | 0.44 % | $ 28.5 M | ||
|
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
326 M | $ 9.85 | 1.86 % | $ 353 M | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Natus Medical Incorporated
NTUS
|
799 M | - | 1.94 % | $ 1.05 B | ||
|
Nevro Corp.
NVRO
|
213 M | - | - | $ 217 M |